Announcement

Collapse
No announcement yet.

Ketamine’s Antidepressant Efficacy is extended 4 weeks with a family history of AUD

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

    Ketamine’s Antidepressant Efficacy is extended 4 weeks with a family history of AUD

    Ketamine’s Antidepressant Efficacy is Extended for at Least Four Weeks in Subjects with a Family History of an Alcohol Use Disorder
    01-01-2014 - Indifference reached, success with high dose Baclofen 295mg.

    Baclofen prescribing guide

    Baclofen for alcoholism - Consolidated Information - Studies, prescribing guides, links

    #2
    Thanks for the info, neo. I had no idea that ketamine had any efficacy for depression, let alone greater efficacy for those of us with this problem. Very interesting!

    Comment


      #3
      Just read this, interesting. -tk
      TerryK celebrates 6 years of sobriety and indifference to alcohol thanks to baclofen

      Comment


        #4
        Researchers seeking volunteers to test effectiveness of ketamine in treating alcoholism - The i newspaper online iNews

        Comment


          #5
          Fellow MWO users: The above user (Wilson1) is the banned MWO member Spiritfree/Spiritwolf/befreenow/Alfree. Please report him and do not allow him to continue on this site. He has done nothing but cause drama and chaos.

          Comment


            #6
            Ketamine...That was in the news a lot in years gone by. This study was only of 54 people, and it included a group on placebo (so not many actually getting ketamine), but it's still interesting. The conclusion:


            Results: FHP subjects randomized to placebo had a greater antidepressant response than FHN subjects; however, contrary to our

            initial hypothesis, there was no significant difference in antidepressant efficacy with riluzole. Although potentially underpowered,

            there was no difference in overall time-to-relapse based on randomization status (riluzole responders: n*=*15, placebo responders:

            n*=*17). Yet, time-to-relapse was longer in FHP placebo responders (n*=*8) compared to FHN placebo responders (n*=*9) with, again,

            no significant difference in time-to-relapse in FHP riluzole responders (n*=*6) compared to FHN riluzole responders (n*=*9).

            Conclusions: Ketamine??s extended antidepressant durability in FHP TRD should be considered in the design and analysis of

            ketamine depression trials.

            Comment

            Working...
            X